[1] Luangsa-Ard J, Houbraken J, van Doorn T, et al. Purpureocillium, a new genus for the medically important Paecilomyces lilacinus[J]. FEMS Microbiology Letters, 2011, 321(2):141-149. [2] Diana Castillo L, Zhu-Salzman K, Maria Julissa E, et al.The entomopathogenic fungal ndophytes Purpureocillium lilacinum(Formerly Paecilomyces lilacinus)and Beauveria bassiana negatively affect cotton aphid reproduction under both greenhouse and field conditions[J]. PLoS One, 2014, 9(8):e103891. [3] Fiedler Ż, Sosnowska D.Nematophagous fungus Paecilomyces lilacinus(Thom)Samson is also a biological agent for control of greenhouse insects and mite pests[J]. BioControl, 2007, 52(4):547-558. [4] Goffré D, Folgarait PJ.Purpureocillium lilacinum, potential agent for biological control of the leaf-cutting ant Acromyrmex lundii[J]. Journal of Invertebrate Pathology, 2015, 130:107-115. [5] 孙漫红, 刘杏忠, 晋治波. 淡紫拟青霉对大豆胞囊线虫卵及龄2幼虫的影响[J]. 植物保护学报, 2002, 29(1):57-61. [6] 孙漫红, 刘杏忠. 淡紫拟青霉发酵滤液对大豆胞囊线虫趋化性的影响[J]. 植物病理学报, 2004, 34(4):376-379. [7] 肖炎农, 王明祖, 王道本. 淡紫拟青霉几丁质酶对南方根结线虫的影响[J]. 中国生物防治, 1997(1):30-32. [8] 李芳, 葛慈斌, 刘波, 等. 淡紫拟青霉次生代谢物质的抑菌效应[J]. 植物保护学报, 2006(1):94-98. [9] 杨婷, 廖美德, 贺玉广, 等. 淡紫拟青霉PL-HN-16促进植物生长活性因子的初步研究[J]. 华北农学报, 2015(6):170-175. [10] 胡海岩, 王华民, 林英姿, 等. 红树林淡紫拟青霉胞外多糖对小鼠DCs吞噬功能的影响[J]. 重庆医学, 2017(31):4321-4324. [11] 李国军, 常城, 葛婷婷, 等. 红树林淡紫拟青霉胞外多糖分离提取及体外抗HSV-1活性初探[J]. 山西医药杂志, 2017(2):123-126. [12] Bode HB, Bethe B, HÖfs R, et al.Big effects from small changes:possible ways to explore nature’s chemical diversity[J]. Chem-biochem, 2002, 3(7):619-627. [13] Prasad P, Varshney D, Adholeya A.Whole genome annotation and comparative genomic analyses of bio-control fungus Purpureocillium lilacinum[J]. BMC Genomics, 2015, 16:1004. [14] Wang G, Liu Z, Lin R, et al.Biosynthesis of antibiotic leucinostatins in bio-control fungus purpureocillium lilacinum and their inhibition on phytophthora revealed by genome mining[J]. PLoS Pathogens, 2016, 12(7):e1005685. [15] Newald JG, Marahiel MA.Chemoenzymatic and template-directed synthesis of bioactive macrocyclic peptides[J]. American Society for Microbiology, 2006, 70(1):121-146. [16] Arai T, Mikami Y, Fukushima K, et al.A new antibiotic, leucinostatin, derived from Penicillium lilacinum[J]. J Antibiot(Tokyo), 1973, 26(3):157-161. [17] Ricci M, Sassi P, Nastruzzi C, et al.Liposome-based formulations for the antibiotic nonapeptide leucinostatin A:fourier transform infrared spectroscopy characterization and in vivo toxicologic study[J]. AAPS PharmSciTech, 2000, 1(1):E2. [18] Park JO, Hargreaves JR, Mcconville EJ, et al.Production of leucinostatins and nematicidal activity of Australian isolates of Paecilomyces lilacinus(Thom)Samson[J]. Letters in Applied Microbiology, 2004, 38(4):271-276. [19] Ishiyama A, Otoguro K, Iwatsuki M, et al.In vitro and in vivo antitrypanosomal activities of three peptide antibiotics:leucinostatin A and B, alamethicin I and tsushimycin[J]. The Journal of Antibiotics, 2009, 6(62):303-308. [20] Kawada M, Inoue H, Momose I, et al.Leucinostatins suppress prostate cancer cell growth through the tumour-stromal cell interactions[J]. European Journal of Cancer Supplements, 2008, 6(12):59-60. [21] Kawada M, Inoue H, Ohba S, et al.Leucinostatin A inhibits prostate cancer growth through reduction of insulin-like growth factor-I expression in prostate stromal cells[J]. International Journal of Cancer, 2010, 126(4):810-818. [22] Abe H, Ouchi H, Sakashita C, et al.Catalytic asymmetric total synthesis and stereochemical revision of leucinostatin A:A modulator of tumor-stroma interaction[J]. Chemistry, 2017, 23(49):11792-11796. [23] 孙宇辉, 邓子新. 聚酮化合物及其组合生物合成[J]. 中国抗生素杂志, 2006, 31(1):6-14, 18. [24] Madariaga-Mazón A, González-Andrade M, González MDC, et al.Absolute configuration of acremoxanthone C, a potent calmodulin inhibitor from Purpureocillium lilacinum[J]. Journal of Natural Products, 2013, 76(8):1454-1460. [25] Melendez-Gonzalez C, Muria-Gonzalez MJ, Anaya AL, et al.Acremoxanthone E, a novel member of heterodimeric polyketides with a bicyclo[3. 2. 2]nonene ring, produced by Acremonium camptosporum W. GAMS(Clavicipitaceae)endophytic fungus[J]. Chem Biodivers, 2015, 12(1):133-147. [26] Isaka M, Palasarn S, Auncharoen P, et al.Acremoxanthones A and B, novel antibiotic polyketides from the fungus Acremonium sp. BCC 31806[J]. Tetrahedron Letters, 2009, 50(3):284-287. [27] Intaraudom C, Bunbamrung N, Dramae A, et al.Acremonidins F-H and acremoxanthones F-G, antimicrobial substances from the insect fungus Verticillium sp. BCC33181[J]. Tetrahedron, 2016, 72(10):1415-1421. [28] Teles APC, Takahashi JA.Paecilomide, a new acetylcholinesterase inhibitor from Paecilomyces lilacinus[J]. Microbiological Research, 2013, 168(4):204-210. [29] Bolognesi ML, Minarini A, Tumiatti V, et al.Progress in acetylcholinesterase inhibitors for Alzheimer’s disease[J]. Expert Opinion on Therapeutic Patents, 2006, 16(6):811-823. [30] Kulshreshtha A, Piplani P.Current pharmacotherapy and putative disease-modifying therapy for Alzheimer’s disease[J]. Neurological Sciences, 2016, 37(9):1403-1435. [31] Ferreira ND, Alencar LJ, Sobreiro FDDA, et al.New semicarbazones as gorge-spanning ligands of acetylcholinesterase and potential new drugs against Alzheimer’s disease:Synthesis, molecular modeling, NMR, and biological evaluation[J]. J Biomol Struct Dyn, 2017:1-15. [32] 崔香, 李长伟, 吴长景, 等. 深海来源淡紫拟青霉ZBY-1的代谢产物及其抗肿瘤活性[J]. 国际药学研究杂志, 2013, 40(2):177-186. [33] 崔香, 李长伟, 吴长景, 等. 淡紫拟青霉ZBY-1的次级代谢产物及其抗肿瘤活性[J]. 国际药学研究杂志, 2013, 40(6):765-771. [34] 李小龙. 淡紫拟青霉518的抗菌活性及其次生代谢产物研究[D]. 南京:南京农业大学, 2012. [35] Teles APC, Takahashi JA.Paecilomide, a new acetylcholinesterase inhibitor from Paecilomyces lilacinus[J]. Microbiological Research, 2013, 168(4):204-210. [36] 李小龙, 王超, 郭坚华. 菌株518鉴定及其次生代谢产物的生防特性与分离[J]. 浙江农业学报, 2013(3):537-542. |